Changing trends in the treatment of dry-eye disease

Author： Dogru Murat   Nakamura Masatsugu   Shimazaki Jun   Tsubota Kazuo  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.12, 2013-12, pp. : 1581-1601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for the treatment of dry eye disease

By Gadaria-Rathod Neha   Lee Kyu-In   Asbell Penny A  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 121-136

Informa Healthcare

Access to resources Recommend Favorite

Clinical decision making in the management of dry eye disease

By PfisterElisabeth   RoseOlaf  

PHARMAKON, Vol. 3, Iss. 5, 2015-09 ,pp. : 371-377

Govi-Verlag

Access to resources Recommend Favorite

Topical 0.05% cyclosporin in the treatment of dry eye

By Perry Henry D   Donnenfeld Eric D  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2099-2107

Informa Healthcare

Access to resources Recommend Favorite

Improve symptoms of dry eye disease by careful selection of appropriate topical treatments

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 12, 2008-12 ,pp. : 12-14

Adis International

Access to resources Recommend Favorite

Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye

By Tang-Liu Diane D.-S.   Acheampong Andrew  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 247-261

Adis International

Access to resources Recommend Favorite